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Abstract
Background: The goal of diabetes control should be feasible in order to minimize the risk of its adverse events and to 
reduce its burden and cost on patients. The current study aimed to assess the status of glycemic control in male and 
female patients with Type 2 Diabetes Mellitus (T2DM) in Kerman, Iran. 
Methods: In the present study, 500 T2DM (300 women and 200 men) from the Kerman Coronary Artery Disease 
Risk Study (KERCADRS), a population-based study from 2009 to 2011, were selected. Patients were >18 years old, 
had Fasting Blood Sugar (FBS) higher than 126 mg/dl, and had been through treatment for their diagnosed disease. 
All participants underwent Glycosylated Hemoglobin (HbA1c) analysis. HbA1c less than 7% was considered as good 
glucose control. Other metabolic indices based on American Diabetes Association (ADA) target recommendations 
were considered. 
Results: The mean level of HbA1c in total subjects was 8.56 ± 4.72% that only 31.66% of men and 26.00% of women had 
controlled level of HbA1c. Total cholesterol less than 200 mg/dl was reported in 64.50% of men and 44.00% of women, 
High Density Lipoprotein (HDL)  more than 40 mg/dl was revealed in 20.50% of men and 34.67% of women, and Low 
Density Lipoprotein (LDL) less than 100 mg/dl was reported in 41.50% of men and 25.33% of women. In multivariate 
logistic regression model, longer duration of disease and higher Waist Circumference (WC) were positively associated 
with uncontrolled diabetes status.
Conclusion: The findings of the present study revealed that diabetes control in T2DM was inadequate. Changing 
the policy of treatment in individual patient and establishing better diabetes clinic to decrease the frequency of 
uncontrolled T2DM are crucial. Paying attention to other affecting metabolic components such as WC in the process 
of T2DM management is important.
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Implications for policy makers
• Given the role of diabetes as an important health related problem in the community, appropriate policies and implementing up-to-date guidelines to 
better control this disease are unavoidable. 
• Diabetes Mellitus (DM) is a complex disease which is correlated with other components of cardiovascular risk factors. So, the assessment of other 
risk factors like dietary pattern, and metabolic risk factors as well as two factors of Waist Circumference (WC) and the duration of the disease (which 
revealed the most important factors of inadequate control of Type 2 Diabetes Mellitus (T2DM) in the present study) should be considered in the 
process of the follow-ups of the patients to reach and achieve the treatment goals of HbA1c <7%. Therefore, more effective management of the disease 
might be required. 
Implications for public
In the present study, we found that the diabetes control was not adequate. However, the patients should realize that in most cases the inadequate diabetes 
control can have several causes such as: irregular use of medication, disregarding physician’s recommendations to modify or change the trend of treatment 
in the course of disease, not paying enough attention to the role of nutrition, exercise/physical activity and weight loss in treatment program. Through 
making changes in the lifestyle of the public, the chance of controlling Type 2 Diabetes Mellitus (T2DM) can be considerably increased; consequently the 
probability of occurrence of other related diseases can be decreased. These simple (in theory) but difficult (in practice) tasks can be effective in preventing 
or delaying the onset of type 2 diabetes. 
Key Messages 
Background
Type 2 Diabetes Mellitus (T2DM) is a leading cause of 
morbidity worldwide, especially with increasing in its 
prevalence occurring in developing countries (1). The 
increasing trend of diabetes is not only dependent to the 
quality of medical care, follow-up of appropriate preventive 
and curative medication regimens as well as good dietary 
habits, but also can be influenced by aging, urbanization, and 
increasing prevalence of obesity and physical inactivity (2). 
According to the report of the World Health Organization 
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(WHO) in 2000, about 170 million people suffered from 
diabetes worldwide and the number will be doubled by 2030 
(3). Because of diabetes-related macrovascular, microvascular 
and neuropathic complications, a tight and consistent glycemic 
control can result lower complications and preventing its 
life-threatening events (4,5). The goal for glycemic control 
should be feasible to minimize risk for adverse events and 
reduce load of complications and cost on patients (6,7). 
Glycosylated Hemoglobin (HbA1c) index has become the 
gold standard for long-term monitoring glycemic control and 
is a validated measurement tool for assessing diabetes status. 
A HbA1c level 6.5% or less has been suggested as controlled 
Diabetes Mellitus (DM) (8–10). The HbA1c goal for diabetic 
patients has been generally considered less than 7%, however 
recent guidelines have emphasized on more stringent goals, 
such as a normal HbA1c value of less than 6% especially in 
individual patients if they are achievable without significant 
hypoglycemia (11). It has been suggested that each percentage 
point increase in HbA1c results in a 10% increase in mortality 
from all forms of coronary heart disease and brain stroke (12). 
Diabetes is a common non-communicable disease among 
Iranian population with a prevalence of 7.7% in the middle-
age group and with poor quality of care expected for eye 
examination (13,14). In 2002, more than 100,000 deaths were 
recorded as a consequence of diabetes in our country (15). 
Even, it is now more likely to be expanded earlier among 
children and teenagers so that a fasting blood glucose of more 
than 100 mg/dl has been detected in 4.1% of Iranian school-
age children and adolescents with the maximum prevalence 
between ages 10 and 14 (16). While, the prevalence of diabetes 
in 25 to 64 years old Iranian adults has been estimated to be 
7.7%, corresponding to about two million adults that only 
half of them are diagnosed (17,18). In addition, the status 
of diabetes control in different urban and rural areas in our 
country has been already unknown and a few epidemiological-
based studies have been conducted to identify trend of the 
diabetic control in our clinical settings. The present study 
was undertaken to assess the status of glycemic control and 
compare this index between male and female patients with 
T2DM by measurement of HbA1c in Kerman, the largest 
province in Iran, through a population-based study. 
Methods
Participants
The Kerman Coronary Artery Disease Risk Study 
(KERCADRS) is a population-based, epidemiological 
research among a cohort of 5,900 individuals (3,238 
women) aged between 15 to 75 years (from 2009 to 2011) 
and residence in Kerman city addressing the information of 
the risk profile of coronary artery disease including serum 
lipids, physical activity, alcohol and drugs addiction, mental 
disorders like stress and depression, hypertension as well 
as dietary regimens. The participants had been recruited 
through a household survey by non-proportional to the size 
one-stage cluster sampling. Non-communicable risk factors 
were collected by both a structured questionnaire (such as 
cigarette and opium smoking, obesity, hypertension, and so 
on) and laboratory measurements (such as HbA1C, Fasting 
Blood Sugar (FBS) and lipid profiles). Interviews were done 
by trained internal specialist, general practitioners, nurses 
and trained interviewers. [The methodology of this research 
has been published elsewhere] (19). 
The participants of the current study were those diabetic 
patients with inclusion criteria of being older than 18 years, 
had FBS higher than 126 mg/dl, and under treatment for 
their diagnosed disease. Additional information in regard 
to the epidemiology of diabetes, pre-diabetes, diagnosed 
and undiagnosed diabetes for the KERCADR study has 
been already published (20). All subjects were identified as 
having diabetes and/or using any hypoglycemic medication 
at the time of their recruitment into the study. Those with 
malignant disease, severe renal insufficiency, cirrhosis, active 
liver disease attributable to viral infection and/or other acute 
infectious or inflammatory disorders were all excluded. 
Clinical and biochemical examinations
Participants underwent a biochemical examination that 
included measurement of HbA1c, fasting glucose, systolic 
and diastolic blood pressure, serum triglyceride, and 
total, Low Density Lipoprotein (LDL), and High Density 
Lipoprotein (HDL) cholesterol. We examined weight and 
standing height expressed as Body Mass Index (BMI) (weight 
in kilograms divided by height in meters squared). The Waist 
Circumference (WC) was measured in a horizontal plane, 
midway between the inferior margin of the ribs and the 
superior border of the iliac crest. Blood pressure was recorded 
using an automatic oscillometric blood pressure recorder 
after at least 5 min of rest in a chair and arm supported at 
heart level. For biochemical analysis, blood samples of 5 ml 
were drawn after 12 h overnight fasting for measuring lipid 
profile, FBS, and HbA1c. Plasma glucose was measured using 
the glucose oxidase peroxidase method. The level of serum 
lipid profile was also determined by standard enzymatic 
procedures. The primary indicator of glycemic control was 
level of HbA1c based on Biorad Variant High Performance 
Liquid Chromatography [HPLC] assay. This measure 
integrates control over the prior 12 weeks. In clinical practice, 
the goal for good control is HbA1c <7%, although it may be as 
low as 6.5% in the absence of hypoglycemia or risk factors for 
hypoglycemia, as mentioned already (7). In the present study, 
controlled T2DM was considered as HbA1c <7%. 
Statistical analysis
Results were presented as Mean ± Standard Deviation (SD) 
for quantitative variables and were summarized by absolute 
frequencies and percentages for categorical variables. 
Categorical variables were compared using Chi-Square test or 
Fisher’s exact test when more than 20% of cells with expected 
count of  less than 5 were observed. Quantitative variables 
were also compared using T-Test or One-way analysis of 
variance (ANOVA) test. Multivariate logistic regression 
analysis was used to determine indicators of uncontrolled 
diabetes status adjusted for age, gender and diagnostic 
criteria. Statistical significance was determined as a P< 0.05. 
All statistical analysis was performed using SPSS 20.0 (SPSS 
Inc., Chicago, Illinois).
Results
Table 1 shows the baseline men and women characteristics. 
There were more females (60.00%) than males (40.00%). 
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The overall mean age was 59.32 ± 10.29 years (median 59 
years, ranged 23 to 86 years) that men were slightly elder 
than women (60.43 years versus 58.58 years, P= 0.055). The 
mean duration of diabetes was 68.84 months in men and 
65.03 months in women (P= 0.540). Insulin users comprised 
11.81% of the study population (men 13.42%, women 
10.21%), while multiple oral medication users were 84.90% 
(men 83.80%, women 86.00%) and others followed both 
controlling approaches (men 2.82%, women 3.71%). Mean 
BMI and WC were significantly more prevalent in women 
than men (P< 0.001). 
Mean systolic and diastolic blood pressures were totally 130.65 
± 21.13 mmHg and 81.02 ± 10.26 mmHg, respectively that 
were statistically similar in both genders. Among lipid profile, 
the mean levels of total cholesterol and LDL were higher in 
women than men, whereas no differences were observed 
across them in terms of serum levels of triglyceride and FBS. 
The current status of HbA1c in both genders is presented in 
Table 2. The mean level of HbA1c in total subjects was 8.56 
± 4.72% (mean 7.80%) that only 31.66% of men and 26% of 
women had controlled level of HbA1c (<7%). 
With respect to the status of controlling blood sugar and lipid 
profile in men and women (Table 3) and based on American 
Diabetes Association (ADA) target recommendations, 
34.50% of men and 35.67% of women achieved FBS <130 mg/
dl and thus meeting the goal. Also, regarding control of lipid 
Table 1. Baseline characteristics of study population with DM (n= 500)
Characteristics Men (n= 200) Women (n= 300) P-value
Age (year) 60.43 ± 10.87 58.58 ± 9.83 0.055
Weight (kg) 76.32 ± 13.18 70.70 ± 13.35 <0.001
Height (cm) 169.95 ± 7.96 157.09 ± 5.88 <0.001
BMI (kg/m2) 26.47 ± 4.68 28.60 ± 4.91 <0.001
WC (cm) 90.82 ± 11.77 94.28 ± 10.64 0.001
Systolic blood pressure (mmHg) 131.11 ± 20.50 131.92 ± 21.72 0.673
Diastolic blood pressure (mmHg) 81.52 ± 10.05 81.49 ± 10.51 0.980
FBS (g/dl) 163.04 ± 62.72 171.05 ± 70.60 0.203
Triglyceride (mg/dl) 185.14 ± 138.13 198.74 ± 162.32 0.323
HDL (mg/dl) 34.26 ± 8.59 38.54 ± 9.52 <0.001
LDL (mg/dl) 115.22 ± 38.68 136.59 ± 44.06 <0.001
Total cholesterol (mg/dl) 183.03 ± 47.17 212.69 ± 55.66 <0.001
HbA1c (%) 8.66 ± 5.98 8.50 ± 3.71 0.738
DM= Diabetes Mellitus; BMI= Body Mass Index; WC= Waist Circumference; FBS= Fasting blood sugar; HDL= High Density Lipoprotein; LDL= Low Density 
Lipoprotein; HbA1c= Glycosylated Hemoglobin.
Table 2. HbA1c status in men and women with DM
HbA1c Men (n= 200) Women (n= 300)
<7.0% 63 (31.66) 78 (26.00)
7.0–7.9% 49 (24.62) 80 (26.67)
8.0–8.9% 37 (18.59) 47 (15.67)
9.0–9.9% 20 (10.05) 36 (12.00)
10.0–10.9% 12 (6.03) 31 (10.33)
11.0–11.9% 10 (5.03) 17 (5.67)
≥12.0% 8 (4.02) 11 (3.67)
HbA1c= Glycosylated Hemoglobin; DM= Diabetes Mellitus. 
P= 0.510.
Table 3. Status of blood sugar and lipid profile in men and women with DM
Item  Men (n= 200) Women (n= 300)
FBS
<130 g/dl 69 (34.50)* 107 (35.67)
≥130 g/dl 131 (65.50) 193 (64.33)
Total cholesterol 
<200 mg/dl 129 (64.50) 132 (44.00)
≥200 mg/dl 71 (35.50) 168 (56.00)
HDL
>40 mg/dl 41 (20.50) 104 (34.67)
≤40 mg/dl 159 (79.50) 196 (65.33)
LDL
<100 mg/dl 83 (41.50) 76 (25.33)
≥100 mg/dl 117 (58.50) 224 (74.67)
Triglyceride 
<150 mg/dl 107 (53.50) 111 ( 37.00) 
≥150 mg/dl 93 (46.50) 189 (63.00)
BMI
<30 kg/m2 165 (82.50) 203 (67.67)
≥ 30 kg/m2 35 (17.50) 97 (32.33)
Systolic blood pressure
<130 mmHg 81 (40.50) 136 (45.33)
≥ 130 mmHg 119 (59.50) 164 (54.67)
Diastolic blood pressure
<90 mmHg 54 (27.00) 84 (28.00) 
≥90 mmHg 146 (73.00) 216 (72.00)
FBS= Fasting blood sugar; DM= Diabetes Mellitus; HDL= High Density 
Lipoprotein; LDL= Low Density Lipoprotein; BMI= Body Mass Index.
*n (%).
profile, total cholesterol less than 200 mg/dl was reported in 
64.50% of men and 44.00% of women, HDL more than 40 
mg/dl was revealed in 20.50% of men and 34.67% of women, 
and LDL less than 100 mg/dl was reported in 41.50% of men 
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and 25.33% of women. 
Univariate associations of baseline factors with glycemic 
control are shown in Table 4. Those with lower total 
triglyceride level (less than 150 mg/dl) had lower mean 
HbA1c value (7.94%) than those with higher total triglyceride 
levels (9.02%). Also, mean HbA1c level was lower in patients 
with LDL level lower than 100 mg/dl (8.08%) compared to 
those with higher LDL level (8.77%). On the other hand, the 
main indicators of uncontrolled diabetes according to HbA1c 
values were high triglyceride and LDL levels. In multivariate 
logistic regression model adjusted for background 
parameters (Table 5), higher duration of disease and higher 
WC were positively associated with uncontrolled diabetes 
status. However, higher lipid profile levels or medications 
for controlling diabetes could not predict uncontrolled 
diabetes status. 
Discussion
The findings of our study show that of the total study 
diabetes patients, only 31.6% of men and 26% of women 
have acceptable HbA1c values of <7%. The remaining ones 
have values above the recommended cut-off and hence an 
undesirable diabetic control status. This result demonstrated 
a notable high prevalence rate of uncontrolled diabetes when 
compared with other similar reports, but is in agreement 
with other reports from different regions of our country. 
In a similar study originated from Iran’s national non-
communicable diseases risk factor surveillance survey, about 
97.4% of the patients had poor control according to their 
most recent HbA1c levels. In this regard, about 25% needed 
an improvement in diabetes control according to their blood 
levels of LDLs, and 45% of them were hypertensive (21). But, 
better diabetes control has been reported from south Asian, 
European and Western countries. Chuang et al. showed that 
55% of the patients from South Asian countries had HbA1c 
values exceeding 8% (22). A retrospective analysis of data 
from 1998–2002 in UK found that >60% of the patients 
had poorly controlled disease regardless of the cut-off used 
to determine good control (23), while a Canadian study 
demonstrated HbA1c of 7.7% for 78% of the patients tested 
(24). The average HbA1c for patients in Australian population 
was 7.3 ± 1.23 (25). The results of a European cohort study 
(RECAP-DM) in 2008 showed that the overall frequency 
of adequate glycemic control among 2,023 T2DM patients 
was one quarter (25.5%) (26). In another international 
longitudinal study (IDMP study) among 11,799 diabetic 
patients, recruited from 17 developing countries in 2009, 
results illustrated that only 20–30% of patients achieved the 
goal of less than 7% for HbA1c (27). The findings of a recent 
multicenter, cross-sectional survey of outpatients carried out 
in 606 hospital in all provinces of China among more than 
230 thousands T2DM demonstrated that less than one third 
of the patients achieved the goal of HbA1c less than 7% (28).
Regarding associated indicators of poor controlled diabetes, 
we evaluated some clinical criteria and found that only 
higher duration of disease and higher WSs were associated 
with this poor diabetes controlling. However, we did not 
Table 4. Mean level of hemoglobin A1c in different risk profile
Item Mean A1c P-value
Gender 
Men 8.66 ± 5.98* 0.738
Women 8.50 ± 3.71 
Age 
<50 years 8.22 ± 2.02
50–65 years 8.43 ± 3.65 0.386
>65 years 9.05 ± 7.30
Disease duration 
<1 years 8.22 ± 5.83
1–5 years 9.04 ± 6.43 0.596
6–10 years 8.50 ± 1.86
>10 years 8.76 ± 1.67
Diabetes control method
Insulin 8.36 ± 1.43
Oral medication 8.76 ± 4.88 0.811
Both 9.26 ± 2.08
Total cholesterol 
<200 mg/dl 8.44 ± 5.30 0.547
≥200 mg/dl 8.69 ± 4.03
HDL
>40 mg/dl 8.33 ± 1.82 0.328
≤40 mg/dl 8.66 ± 5.50
LDL
<100 mg/dl 8.08 ± 1.65 0.034
≥100 mg/dl 8.77 ± 5.53
Triglyceride 
<150 mg/dl 7.94 ± 1.75 0.005
≥150 mg/dl 9.02 ± 5.99
BMI
<30 kg/m2 8.55 ± 4.51 0.920
≥30 kg/m2 8.60 ± 5.27
Systolic blood pressure
<130 mmHg 8.79 ± 5.69 0.375
≥130 mmHg 8.39 ± 3.81
Diastolic blood pressure
<90 mmHg 8.74 ± 5.09 0.625
≥90 mmHg 8.49 ± 4.58
HDL= High Density Lipoprotein; LDL= Low Density Lipoprotein; BMI= 
Body Mass Index.
*Mean ± standard deviation.
Table 5. Multiple model for determining indicators of uncontrolled DM
Characteristics Odds Ratio 95% CI P-value
Male gender 0.80 0.32–2.00 0.637
Age 0.99 0.95–1.03 0.799
BMI 0.94 0.85–1.05 0.264
WC 1.06 1.00–1.11 0.038
Disease duration 1.01 1.00–1.02 0.016
Diabetes control regimen 0.62 0.14–2.06 0.514
Systolic blood pressure 0.99 0.96–1.01 0.356
Diastolic blood pressure 1.02 0.96–1.08 0.482
LDL 0.99 0.99–1.01 0.868
Total triglyceride 1.00 0.99–1.01 0.910
DM= Diabetes Mellitus; BMI= Body Mass Index; WC= Waist Circumference; 
HDL= High Density Lipoprotein; LDL= Low Density Lipoprotein; HbA1c= 
Glycosylated Hemoglobin.
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consider socio-economic characteristics for this aim that 
might be powerful indicators. On the other hand, the most 
important factor associated with poor control diabetes status 
can be some clinical risk profiles including central obesity 
and disease duration, however potential effects of some other 
determinants such as inadequate knowledge of patients and 
even care providers should not be ignored. According to 
some surveys, lack of adequate knowledge about the disease 
is a principle affecting factor. In this regard, in a study among 
Pakistani diabetic population, 58% of the patients lacked 
appropriate education for disease management that also had 
the highest levels of HbA1c of 9.98% (29). Another main 
factors pointed in other studies was financial burden imposed 
on the patients accounts for the majority of the patients with 
suboptimum HbA1c levels. Inaccessibility to healthcare 
facilities, psychosocial influences, low level of self-care, and 
no adherence to treatment are other limiting factors for 
developing countries (30–33). 
Regarding association between obesity (high WC) and poor 
diabetes control, it has been suggested that adults with insulin 
dependent diabetes are often obese, and this may adversely 
affect their diabetic control, resulting in complications (34). 
WC alone has been identified as a strong determinant for 
glucose exacerbation and glycemic relapse among people 
with T2DM and more predictive than other components of 
metabolic syndrome (35), although BMI was also another 
powerful predictor of insulin resistance (36) and poor control 
of diabetes. Blaha et al. (35) showed that WC had a positive 
significant correlation with increased risk of hyperglycemic 
recurrence in both simple analysis (hazard ratio: 3.4) and 
multivariate analysis (hazard ratio: 3.2). Such findings was 
recognized in a study by Janiszewski et al. (37), which in a 
cross-sectional study among around 6,000 individuals from 
the U.S. showed that WC was significantly considered as a 
major predictor of blood glucose levels. Obesity along with 
other risk factors such as physical inactivity and unsound 
diet regime have been known as significant determinants 
of insulin resistance and beta-cell failure (as physiologic 
factors), which can consequently lead to inadequate T2DM 
control (38). 
We found a direct association between poor diabetes control 
and disease duration. Similarly, Otiniano et al. (39) found that 
subjects with poor control had longer disease duration, had 
lower education, used the glucometer more frequently, and 
had more diabetes-complications when compared to those 
in the good glycemic control group. In the multivariable 
analysis, longer disease duration besides low educational 
level, foreign-born, smoking, obesity, daily glucometer use, 
and having macro-complications were main determinants 
of poor diabetes control. Study by Longo-Mbenz et al. (40) 
duration diabetes ≥4 years was significantly associated with 
the presence of diabetic complications and its inappropriate 
controlling. In a study in Jordan among patients with T2DM, 
it was shown two factors of longer duration of DM and poor 
adherence to behaviors related to self-care management 
were significantly (in the multivariate analysis) associated 
with inadequate control of DM, which around two third of 
the T2DM patients had HbA1c ≥7% (41). Our results were 
consistent with the findings of these studies. It has been studied 
that advanced age and duration of diabetes have a significant 
association with increased likelihood of insulin resistance and 
levels of HbA1c (42). It is determined that aging and longer 
duration of diabetes are significant predictors of uncontrolled 
HbA1c which may lead to chronic hyperglycemic and insulin 
insensitivity (43). The main cause of this association might be 
related to more highlighted effect of longer diabetes duration 
and higher prevalence of other diabetes disease risk factors 
such as hyperlipidemia as well as complication of disease that 
can potentially result in more severe disease status and more 
severe disease control. 
Although we did not obtain any relationship between poor 
glycemic control and type of treatment approach of diabetes, 
some authors showed that the subgroup of patients not treated 
with insulin presented relatively lower rates of poor glycemic 
control, while those with type 2 diabetes using insulin had 
a prevalence of inadequate glycemic control. One survey by 
Arai et al. (44) in Japan and another study by Yu et al. (45) 
in Taiwan also reported lower mean levels of HbA1c among 
patients not requiring insulin. These differences changed 
after stratifying the data by diabetes duration, but even among 
patients at earlier stage of diabetes (<5 years duration) insulin 
treatment was associated with worse control when compared 
to diet alone or combined with oral treatment, possibly due 
to more severe and more difficult to control diabetes in the 
former patients.
We found no significant difference in glycemic control 
by gender. Several studies have failed to show significant 
gender differences related to self-care and control of diabetes 
(46–49). Contrarily, in a study in a Pakistani Muslim diabetic 
population in UK, women were worse than men in performing 
regular glucose measurements, in managing persistent 
hyperglycemia, and had also poorer glycemic control overall 
(HbA1c 8.8% vs. 8.1%, P< 0.05) (50). Results from a survey 
in Mexico have suggested that women have several social 
disadvantages, deterioration of healthy life, poor self-care and 
lack of solidarity that increases their vulnerability to reach 
glycemic control successfully (51). 
Strengths and limitations
The distinctive strengths of this study are the large 
provincial sample, the data collection by trained and 
certified interviewers from general practitioners not part of 
the local center staff, and the measurement of HbA1c by a 
reliable method in a single central laboratory. Despite that, 
one limitation is that the study did not assess most of socio-
economic factors for determining indicators of poor diabetes 
control such as their education level, income, level of physical 
activity, and dietary habits. 
Conclusion
Diabetes control in these Kermanian diabetic patients is 
not adequate as shown by very high rates of poor control 
of HbA1c, because of poor diabetes care and management. 
Longer diabetes duration and obesity are significantly 
associated with poor control of diabetes.
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